Skip to main content

LIPOPROTEIN (A)

December 21 2021
Lipoprotein(a) (Lp(a)) is now being tested in-house at LifeLabs effective December 13th, 2021.
Lipoprotein(a) (Lp(a)) levels are robustly associated with the risk of coronary heart disease; strongly suggesting a causal association between Lp(a) and cardiovascular disease (CVD). In accordance with the 2021 CCS guidelines and the recently introduced Ontario Ministry of Health’s Community Access Pilot (see LifeLabs notice from December 13th, 2021), LifeLabs is now offering Lp(a) testing performed in house, at no cost to patient. The Lp(a) results are available with improved turnaround time of one day and expressed in nmol/L units. See the attached memo for more information.

Lipoprotein(a) (Lp(a)) is now being tested in-house at LifeLabs effective December 13th, 2021.

Lipoprotein(a) (Lp(a)) levels are robustly associated with the risk of coronary heart disease; strongly suggesting a causal association between Lp(a) and cardiovascular disease (CVD). In accordance with the 2021 CCS guidelines and the recently introduced Ontario Ministry of Health’s Community Access Pilot (see LifeLabs notice from December 13th, 2021), LifeLabs is now offering Lp(a) testing performed in house, at no cost to patient. The Lp(a) results are available with improved turnaround time of one day and expressed in nmol/L units. See the attached memo for more information.

HCPs
Newsletters

Read More
The stethoscope on the doctor's Desk

Scientific Publications

Read More
Scientist looking through a microscope in a laboratory

Your health & safety is important to us

Please note that face masks are mandatory at all times at all of our locations to ensure the health and safety of all customers and employees.

Please inform staff if you are unable to wear a mask due to a medical condition. 

Thank you for your cooperation!